Profile banner
Bruce McClenathan

Bruce McClenathan

Executive Medical Director — Vaccinology, immunization research, and medical affairs

Sanford, North Carolina
usuhs
Fort Bragg, North Carolina
usuhs+1
Favicon imageusuhs.edu
Favicon imageorcid.org
Favicon imageallucent.com
Favicon imageallucent.com

Summary

Vaccine safety and immunization research leader: McClenathan has extensive experience designing, conducting, and overseeing vaccine safety and immunization research, including NIH-funded studies and metabolomics work aimed at identifying biomarkers of adverse vaccine reactions. usuhs+2
Military medical and operational leadership: He served in multiple leadership roles within military medical centers and the Defense Health Agency, applying clinical vaccinology and force health protection principles to vaccine programs and readiness. usuhs+2
Clinical investigator and scientific author: McClenathan is a contributing author on peer-reviewed vaccine and vaccine-safety publications (including a JAMA Cardiology case series) and has published metabolomics research exploring biomarkers of adverse vaccine events. nih+2
CRO medical affairs and federal research expertise: In his Allucent role he provides medical and scientific oversight for government- and public-health-focused clinical research, serving as a Task Order/Project Award Principal Investigator and advising on protocol design, medical monitoring, and federal contracting requirements. allucent+2

Work

Education

Projects

Writing

The Strategic Role of the CRO Principal Investigator: Improving Biotech Sponsors Through Protocol Design and Study Execution

September 1, 2025

Article describing the role and value of CRO-affiliated Principal Investigators in protocol design, medical oversight, and execution of government-funded and biotech clinical trials; includes a biographical note describing McClenathan's role at Allucent.

Favicon imageallucent.com

Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military

October 1, 2021

Retrospective case series describing 23 cases of clinically diagnosed myocarditis identified within the Military Health System after mRNA COVID-19 vaccination, characterizing clinical presentation, diagnostic findings, and the temporal association with vaccination.

Favicon imagepubmed.ncbi.nlm.nih.gov

Metabolites as Biomarkers of Adverse Reactions Following Vaccination: A Pilot Study using Nuclear Magnetic Resonance Metabolomics

March 1, 2017

Pilot study investigating whether serum metabolite profiles can identify subjects predisposed to adverse events following immunization, including myopericarditis, aiming to find biomarkers to improve immunization safety.

Favicon imagemetabolomicsworkbench.org